Patents by Inventor Charles Wilson

Charles Wilson has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250111135
    Abstract: Disclosed is a range preview system that displays data from a relevant range of cells. The range preview system intelligently elides and contextualizes data ranges for efficient visualization. The range preview system optimizes space utilization by selectively collapsing rows and columns. For example, rows and columns that are referenced by a formula may be selected for inclusion in the range preview. This conserves screen real estate while providing users with a concise overview of data ranges. The range preview system may also infer labels, providing context during formula interpretation by associating references with nearby headers or other descriptions.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 3, 2025
    Inventors: Advait SARKAR, Sruti SRINIVASA RAGAVAN, John Herbert Martin WILLIAMS, Ian Zachariah DROSOS, Nicholas Charles WILSON, Irena BEREZOVSKY, Lev SOLODKIN, Andrew Donald GORDON
  • Publication number: 20250111134
    Abstract: Disclosed are novel approaches to debugging a formula in a spreadsheet environment. An execution trace shows step-by-step how a formula is evaluated. Instead of overwhelming users by displaying a step for every atomic evaluation, multiple evaluations are displayed in the same step. This makes the execution trace compact yet intuitive, enabling users to quickly and efficiently understand how the formula is evaluated. Visualizing formula execution in this way also reduces the computing and energy costs of excess recalculations incurred by trial-and-error based debugging techniques.
    Type: Application
    Filed: December 29, 2023
    Publication date: April 3, 2025
    Inventors: Advait SARKAR, Sruti SRINIVASA RAGAVAN, John Herbert Martin WILLIAMS, Ian Zachariah DROSOS, Nicholas Charles WILSON, Irena BEREZOVSKY, Lev SOLODKIN, Andrew Donald GORDON
  • Publication number: 20250084105
    Abstract: The present invention provides compounds, compositions thereof, and processes for preparing same.
    Type: Application
    Filed: November 21, 2024
    Publication date: March 13, 2025
    Inventors: William Leong, Dharyl Charles Wilson
  • Patent number: 12239788
    Abstract: A patient interface, such as a nasal cannula, including a body to be positioned upon a user (preferably such as a user's face), the body including at least one (and preferably a pair of) nasal prong(s), the or each nasal prong including a lumen capable of being fluidly connected thereto for fluid communication with a supply of breathable gas, the or each nasal prong to be in a configuration either inserted into, or to direct a flow of gas toward, a nare or the nares of the user's nose, wherein the body includes at least one element responsive to force(s) or movement(s), or both, experienced by at least a first region of the patient interface.
    Type: Grant
    Filed: July 30, 2021
    Date of Patent: March 4, 2025
    Assignee: Fisher & Paykel Healthcare Limited
    Inventors: Michael Paul Ronayne, Riki Zane Shearer, Daniel Charles Wilson, Robert Andrew David Milne, Caroline Geraldine Hopkins, Craig Karl White, Puqing Zhang
  • Publication number: 20250068835
    Abstract: A data processing system implements receiving a first input in a spreadsheet in a spreadsheet application, detecting an indication that the first input includes first executable program code, analyzing the first executable program code to identify first references to one or more first elements of the spreadsheet in the first executable program code, requesting spreadsheet data associated with the one or more first elements of the spreadsheet from the spreadsheet application, receiving the spreadsheet data from the spreadsheet application; executing the first executable program code using the spreadsheet data referenced in the first executable program code to obtain a first program code result and causing the spreadsheet application to display the first program code result in the spreadsheet application.
    Type: Application
    Filed: August 21, 2023
    Publication date: February 27, 2025
    Applicant: Microsoft Technology Licensing, LLC
    Inventors: Joseph John MCDAID, Keyur PATEL, Arturo GOICOCHEA HOEFKEN, Eoin BURKE, Su-Piao WU, James MASSON, Christopher GROSS, Jake Elliot ARMSTRONG, Carlos Augusto OTERO, John Herbert Martin WILLIAMS, Nicholas Charles WILSON, Andrew Donald GORDON, Neil TORONTO, Anders HEJLSBERG, Guido VAN ROSSUM, Shaofeng ZHU, Stephen DOWER, John LAM
  • Publication number: 20250050049
    Abstract: A patient interface, such as a nasal cannula is described. The patient interface has a body portion to be located, in-use upon a face of a user. The body portion has at least one side arm that extends laterally from a central bridge portion to be located about a user's septum region, where each side arm is connected to a resilient, or relatively more rigid, bridge portion element. The interface has at least one, and preferably a pair of, nasal prong(s). The body portion has at least one fluid passageway connected to the nasal prong(s) for supply of a gas to the nare(s) of the user's nose. A cross section of the passageway varies along the length of the body portion to regions of varying flexibility along the body portion. The bridge portion element defines a substantially predetermined spatial relationship for outlet(s) of a gas delivery system supplying gas via each side arm to the outlet(s) from which, for example, the nasal prong(s) may be provided in fluid connection.
    Type: Application
    Filed: June 18, 2024
    Publication date: February 13, 2025
    Inventors: Chelsea Erin Johnson, Robert Andrew David Milne, Riki Zane Shearer, Michael Paul Ronayne, Daniel Charles Wilson, Leon Tyler Stanley
  • Publication number: 20250025553
    Abstract: The present invention relates to the use of a specific binding molecules which binds human ANXA1 in combination with a second active agent for use in the treatment of cancer. Second active agents include thy midylate synthetase inhibitors, nucleobase analogues, checkpoint inhibitors, proteasome inhibitors, taxanes, platinum-based chemotherapy agents and nucleoside analogues. Preferred cancers for treatment are pancreatic cancer, colorectal cancer, breast cancer, lung cancer, myeloma and mantle cell lymphoma. Related kits, products and uses are also provided.
    Type: Application
    Filed: November 18, 2022
    Publication date: January 23, 2025
    Applicant: Medannex Ltd.
    Inventors: Henry Charles Wilson HAYS, Chirstopher Barry WOOD, Fiona Carolyn DEMPSEY, Scott James CRICHTON, James Alexander INGHAM, Charlene FABIAN
  • Patent number: 12187744
    Abstract: The present invention provides compounds, compositions thereof, and processes for preparing same.
    Type: Grant
    Filed: October 28, 2022
    Date of Patent: January 7, 2025
    Assignee: Kymera Therapeutics, Inc.
    Inventors: William Leong, Dharyl Charles Wilson
  • Publication number: 20240390495
    Abstract: Genetically engineered hematopoietic cells, which express one or more factors that redirect glucose metabolites, and optionally a chimeric receptor polypeptide (e.g., an antibody-coupled T cell receptor (ACTR) polypeptide, a chimeric antigen receptor (CAR) polypeptide, or a TCR polypeptide) capable of binding to a target antigen of interest. Also disclosed herein are uses of the engineered hematopoietic cells for inhibiting cells expressing a target antigen in a subject in need thereof.
    Type: Application
    Filed: September 27, 2022
    Publication date: November 28, 2024
    Applicant: SOTIO BIOTECH INC.
    Inventors: Kathleen MCGINNESS, Seth ETTENBERG, Luke BARRON, Michael FRAY, Charles WILSON, Gregory MOTZ, Samyabrata BHADURI, Amy JENSEN, Emily KUIPER
  • Publication number: 20240376442
    Abstract: Disclosed herein are genetically engineered hematopoietic cells, which express one or more Krebs cycle modulating polypeptides, and optionally a chimeric receptor polypeptide (e.g., an antibody-coupled T cell receptor (ACTR) polypeptide or a chimeric antigen receptor (CAR) polypeptide) capable of binding to a target antigen of interest. Also disclosed herein are uses of the engineered hematopoietic cells for inhibiting cells expressing a target antigen in a subject in need thereof.
    Type: Application
    Filed: July 25, 2024
    Publication date: November 14, 2024
    Applicant: SOTIO BIOTECH INC.
    Inventors: Kathleen McGinness, Seth Ettenberg, Luke Barron, Michael Fray, Charles Wilson, Gregory Motz
  • Patent number: 12077785
    Abstract: Disclosed herein are genetically engineered hematopoietic cells, which express one or more Krebs cycle modulating polypeptides, and optionally a chimeric receptor polypeptide (e.g., an antibody-coupled T cell receptor (ACTR) polypeptide or a chimeric antigen receptor (CAR) polypeptide) capable of binding to a target antigen of interest. Also disclosed herein are uses of the engineered hematopoietic cells for inhibiting cells expressing a target antigen in a subject in need thereof.
    Type: Grant
    Filed: August 14, 2019
    Date of Patent: September 3, 2024
    Assignee: SOTIO BIOTECH INC.
    Inventors: Kathleen McGinness, Seth Ettenberg, Luke Barron, Michael Fray, Charles Wilson, Gregory Motz
  • Publication number: 20240277166
    Abstract: A pillow uses a fan assembly in the pillow to cool the sleeping surface of the pillow. The fan assembly uses two fans to move ambient air through a middle layer of reticulated foam and then through air passages extending through at least one layer of foam. A bottom piece of foam is either semi-permeable or impermeable to airflow so that most, if not all, of the air moved by the fans exits the top of the pillow to cool the pillow. A chargeable power source powers the fans via a circuit board which may have an LED light to indicate the status of the power source.
    Type: Application
    Filed: February 20, 2023
    Publication date: August 22, 2024
    Inventors: Seth Thompson, Charles Wilson, Matthew D. McKnight, Sydney Wells
  • Patent number: 12048814
    Abstract: A patient interface, such as a nasal cannula is described. The patient interface has a body portion to be located, in-use upon a face of a user. The body portion has at least one side arm that extends laterally from a central bridge portion to be located about a user's septum region, where each side arm is connected to a resilient, or relatively more rigid, bridge portion element. The interface has at least one, and preferably a pair of, nasal prong(s). The body portion has at least one fluid passageway connected to the nasal prong(s) for supply of a gas to the nare(s) of the user's nose. A cross section of the passageway varies along the length of the body portion to regions of varying flexibility along the body portion. The bridge portion element defines a substantially predetermined spatial relationship for outlet(s) of a gas delivery system supplying gas via each side arm to the outlet(s) from which, for example, the nasal prong(s) may be provided in fluid connection.
    Type: Grant
    Filed: June 16, 2021
    Date of Patent: July 30, 2024
    Assignee: FISHER & PAYKEL HEALTHCARE LIMITED
    Inventors: Chelsea Erin Johnson, Robert Andrew David Milne, Riki Zane Shearer, Michael Paul Ronayne, Daniel Charles Wilson, Leon Tyler Stanley
  • Patent number: 12011710
    Abstract: Bulk catalysts comprised of nickel, molybdenum, tungsten and titanium and methods for synthesizing bulk catalysts are provided. The catalysts are useful for hydroprocessing, particularly hydrodesulfurization and hydrodenitrogenation, of hydrocarbon feedstocks.
    Type: Grant
    Filed: June 29, 2023
    Date of Patent: June 18, 2024
    Assignee: CHEVRON U.S.A. INC.
    Inventors: Xiaoying Ouyang, Viorel Duma, Alexander Kuperman, Ibrahim Uckung, Theodorus Ludovicus Michael Maesen, Axel Brait, Charles Wilson
  • Patent number: D1043705
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: September 24, 2024
    Assignee: NETIMPACT STRATEGIES INC
    Inventors: Praveen Chandra Kosgi, Charles Wilson
  • Patent number: D1043706
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: September 24, 2024
    Assignee: NETIMPACT STRATEGIES INC
    Inventors: Praveen Chandra Kosgi, Charles Wilson
  • Patent number: D1043707
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: September 24, 2024
    Assignee: NETIMPACT STRATEGIES INC
    Inventors: Praveen Chandra Kosgi, Charles Wilson
  • Patent number: D1043736
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: September 24, 2024
    Assignee: NETIMPACT STRATEGIES INC
    Inventors: Praveen Chandra Kosgi, Charles Wilson
  • Patent number: D1043737
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: September 24, 2024
    Assignee: NETIMPACT STRATEGIES INC
    Inventors: Praveen Chandra Kosgi, Charles Wilson
  • Patent number: D1043747
    Type: Grant
    Filed: April 26, 2022
    Date of Patent: September 24, 2024
    Assignee: NETIMPACT STRATEGIES INC
    Inventors: Praveen Chandra Kosgi, Charles Wilson